Enanta Pharmaceuticals
ENTA
#7627
Rank
NZ$0.67 B
Marketcap
NZ$23.32
Share price
-0.51%
Change (1 day)
131.93%
Change (1 year)

EPS for Enanta Pharmaceuticals (ENTA)

EPS in 2025 (TTM): NZ-$6.63

According to Enanta Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ-$6.52. In 2024 the company made an earnings per share (EPS) of NZ-$8.43.

EPS history for Enanta Pharmaceuticals from 2013 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ-$6.63-21.41%
2024NZ-$8.43
2021NZ-$8.4872.92%
2020NZ-$4.91-267.44%
2019NZ$2.93-61.35%
2018NZ$7.58147.22%
2017NZ$3.07-460%
2016NZ-$0.85-114.88%
2015NZ$5.72-23.81%
2014NZ$7.51-244.12%
2013NZ-$5.21

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.88-328.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.96-283.29%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$3.50-153.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$28.98-544.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.06-192.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.06-192.95%๐Ÿ‡บ๐Ÿ‡ธ USA